Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.04 Insider Own0.28% Shs Outstand396.75M Perf Week14.88%
Market Cap86.97M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float15.83M Perf Month59.30%
Income-13.45M PEG- EPS next Q- Inst Own1.72% Short Float0.61% Perf Quarter41.24%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.29 Perf Half Y-9.87%
Book/sh1.19 P/B4.61 EPS next Y- ROA-31.64% Short Interest0.10M Perf Year-44.98%
Cash/sh0.92 P/C5.98 EPS next 5Y- ROE-33.34% 52W Range1.96 - 12.68 Perf YTD18.10%
Dividend Est.- P/FCF- EPS past 5Y0.94% ROI-70.14% 52W High-56.78% Beta2.38
Dividend TTM- Quick Ratio6.70 Sales past 5Y-0.90% Gross Margin- 52W Low179.59% ATR (14)1.02
Dividend Ex-Date- Current Ratio6.70 EPS Y/Y TTM0.83% Oper. Margin0.00% RSI (14)56.78 Volatility23.86% 18.67%
Employees- Debt/Eq0.02 Sales Y/Y TTM-100.00% Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q- Payout- Rel Volume0.44 Prev Close5.43
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume336.44K Price5.48
SMA2028.79% SMA5031.20% SMA200-0.99% Trades Volume147,461 Change0.92%
Feb-28-24 07:30AM
Feb-16-24 07:30AM
Feb-01-24 07:30AM
Jan-24-24 04:05PM
Jan-18-24 08:22AM
07:30AM Loading…
Jan-17-24 07:30AM
Dec-21-23 04:05PM
Dec-06-23 07:30AM
Nov-29-23 01:40PM
Nov-16-23 08:30AM
Sep-08-23 07:30AM
Aug-24-23 01:15PM
Aug-23-23 11:45AM
Aug-22-23 07:30AM
08:00AM Loading…
Aug-08-23 08:00AM
Jul-28-23 07:30AM
Jul-27-23 01:20PM
Jul-26-23 07:30AM
Jul-21-23 09:09AM
Jul-18-23 02:30PM
Jul-13-23 08:00AM
Jul-11-23 03:00PM
Jul-10-23 07:30AM
Jul-06-23 08:42AM
Jun-23-23 08:00AM
Jun-19-23 11:20AM
Jun-16-23 08:00AM
Jun-01-23 12:15PM
08:00AM Loading…
May-30-23 08:00AM
May-16-23 07:50AM
May-05-23 07:30AM
May-03-23 02:20PM
May-02-23 07:30AM
Apr-25-23 08:00AM
Apr-14-23 07:30AM
Mar-16-23 08:51AM
Mar-15-23 12:55PM
Mar-03-23 01:30PM
Feb-28-23 05:30PM
Jan-18-23 08:00AM
Dec-06-22 08:00AM
Nov-29-22 08:00AM
Nov-28-22 08:00AM
Nov-17-22 08:00AM
Oct-28-22 08:00AM
Oct-13-22 08:00AM
Oct-11-22 08:00AM
Sep-08-22 09:15AM
Aug-17-22 08:00AM
Aug-10-22 04:36PM
Aug-02-22 07:55AM
Jul-27-22 07:55AM
Jul-21-22 07:55AM
Jun-27-22 06:55AM
Jun-03-22 07:55AM
May-17-22 07:55AM
May-12-22 07:55AM
May-10-22 07:55AM
Apr-28-22 07:55AM
Apr-06-22 11:30AM
Mar-24-22 08:47AM
Mar-23-22 03:06AM
Mar-16-22 04:23PM
Mar-15-22 03:51PM
Mar-10-22 11:43AM
Mar-03-22 07:55AM
Feb-28-22 07:55AM
Incannex Healthcare, Inc. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It operates through the following segments: Psychedelic Products, Cannabinoid Products, and Corporate. The Psychedelic Products segment is involved in the use of psychedelic medicine and therapies for the treatment of mental health disorders. The Cannabinoid Products segment focuses on the use of medicinal cannabinoid products. The Corporate segment includes management of the organization, capital management, and management of resources. The company was founded on April 27, 2001 and is headquartered in New York, NY.